SWEDENCARE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.2 SEK | -0.25% |
|
+5.81% | -2.89% |
| Apr. 25 | Transcript : Swedencare AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Swedencare AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2024 * | 2.66B 253M | Sales 2025 * | 3B 285M | Capitalization | 9.4B 893M |
|---|---|---|---|---|---|
| Net income 2024 * | 228M 21.66M | Net income 2025 * | 343M 32.59M | EV / Sales 2024 * | 3.91 x |
| Net Debt 2024 * | 1B 95.06M | Net Debt 2025 * | 488M 46.36M | EV / Sales 2025 * | 3.3 x |
| P/E ratio 2024 * |
41.2
x | P/E ratio 2025 * |
27.4
x | Employees | 552 |
| Yield 2024 * |
0.84% | Yield 2025 * |
1.35% | Free-Float | 30.45% |
More Fundamentals
* Assessed data
More news
Latest transcript on Swedencare AB
More press releases
| 1 day | -0.25% | ||
| 1 week | +5.81% | ||
| 1 month | +4.59% | ||
| 3 months | +8.94% | ||
| 6 months | +0.34% | ||
| Current year | -2.89% |
1 week
55.90
59.50
1 month
53.0559.50
Current year
52.1069.12
1 year
32.5669.12
3 years
22.90159.00
5 years
11.60159.00
10 years
2.80159.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 13-12-31 | |
Jenny Graflind
DFI | Director of Finance/CFO | 48 | 16-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 22-12-31 | |
| Director/Board Member | 57 | 15-12-31 | |
| Director/Board Member | 61 | 18-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 746 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 59.2 | -0.25% | 283,666 |
| 24-05-30 | 59.35 | +0.59% | 63,269 |
| 24-05-29 | 59 | +0.51% | 53,386 |
| 24-05-28 | 58.7 | +2.98% | 58,811 |
| 24-05-27 | 57 | +1.88% | 32,414 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT
More quotes
Swedencare publ AB is a Sweden-based company, which is mainly involved in the veterinary supplies industry. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores and pharmacies. It operates through four subsidiaries, namely SDC Distribution for Scandinavian countries, Buccosante located in France, Informpet in the United Kingdom and SwedencareUSA in the United States. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Powder, ProDen PlaqueOff Powder Cat and ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
Sector
Pharmaceuticals
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
59.2
SEK
Average target price
67
SEK
Spread / Average Target
+13.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.89% | 892M | |
| +18.66% | 8.74B | |
| +23.75% | 3.67B | |
| -0.42% | 3.25B | |
| +18.07% | 1.73B | |
| -16.99% | 1.38B | |
| -0.39% | 1.31B | |
| -26.05% | 1.24B | |
| -17.86% | 1.07B | |
| -6.77% | 976M |
- Stock Market
- Equities
- SECARE Stock
